相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
Hong Wang et al.
GENE (2020)
ANKLE1 N6-Methyladenosine-related variant is associated with colorectal cancer risk by maintaining the genomic stability
Jianbo Tian et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling
Jinjin Yu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong et al.
MOLECULAR PHARMACOLOGY (2020)
Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
Qianqian Meng et al.
PHARMACOGENOMICS JOURNAL (2020)
Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
Xiaozhen Dai et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
Yue Wang et al.
ACTA PHARMACEUTICA SINICA B (2020)
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Omprakash Shriwas et al.
APOPTOSIS (2020)
The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
Sasithorn Wanna-udom et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression
Masataka Nakano et al.
BIOCHEMICAL PHARMACOLOGY (2020)
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
Alessio Malacrida et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Targeting complex, adaptive responses in melanoma therapy
Phil Cheng et al.
CANCER TREATMENT REVIEWS (2020)
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Xin Cao et al.
DRUG RESISTANCE UPDATES (2020)
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa Narayanan et al.
DRUG RESISTANCE UPDATES (2020)
Linking m6A to Wnt signaling
Xiao-Min Liu et al.
EMBO REPORTS (2020)
FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13
Shenxiang Liu et al.
EXPERIMENTAL CELL RESEARCH (2020)
RNA m6A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c-Met
Guangying Luo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Jie Su et al.
NATURE (2020)
N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial-Mesenchymal Transition of Cancer Cells
Jiexin Li et al.
CELLS (2020)
Extrachromosomal DNA d relieving heredity constraints, accelerating tumour evolution
C. Bailey et al.
ANNALS OF ONCOLOGY (2020)
Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld et al.
CANCER CELL (2020)
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang et al.
CANCER CELL (2020)
N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation
Xiaofei Gu et al.
CELLULAR SIGNALLING (2020)
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang et al.
DRUG RESISTANCE UPDATES (2020)
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Sabrina Dallavalle et al.
DRUG RESISTANCE UPDATES (2020)
Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
Luyao Long et al.
DRUG RESISTANCE UPDATES (2020)
RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy
Ziyou Lin et al.
EMBO JOURNAL (2020)
Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells
Fanhua Kong et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
MP17-01 CIRCMORC3 CONTRIBUTES TO CISPLATIN-RESISTANCE BY AFFECTING M6A MODIFICATION ON DNA DAMAGE RESPONSE RELATED GENES IN BLADDER CANCER
Yinjie Su* et al.
JOURNAL OF UROLOGY (2020)
TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple
Runa Zhang et al.
ONCOGENESIS (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Recent Patents on the Development of c-Met Kinase Inhibitors
Xiangming Xu et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2020)
Can CYP Inhibition Overcome Chemotherapy Resistance?
Magnus Ingelman-Sundberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification (vol 2020, 9250512, 2020)
Xuan Zhang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin et al.
DRUG RESISTANCE UPDATES (2020)
Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
Elisabeth Perez-Ruiz et al.
DRUG RESISTANCE UPDATES (2020)
Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study
Paula Restrepo et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Emerging Mechanisms by which EMT Programs Control Stemness
Molly M. Wilson et al.
TRENDS IN CANCER (2020)
Methylation of RNA N6-methyladenosine in modulation of cytokine responses and tumorigenesis
Guoqiang Chang et al.
CYTOKINE (2019)
METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes
Huiwen Song et al.
AUTOPHAGY (2019)
An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
Mohammad B. Uddin et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
Jonathan Cooper et al.
CANCER CELL (2019)
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Li Zhong et al.
CANCER LETTERS (2019)
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications
Matthieu Gobin et al.
CANCER RESEARCH (2019)
EGF receptor and PKC kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases
Angela M. Ohm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
RNA m(6)A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2
Ujwal Dahal et al.
MELANOMA RESEARCH (2019)
Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology
Amit J. Sabnis et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site
Simona Selberg et al.
CELL REPORTS (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy
Charlie Gourley et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
Hongtao Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
Yidi Qu et al.
MOLECULAR CANCER (2019)
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Hailing Shi et al.
MOLECULAR CELL (2019)
Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1
Shiming Peng et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
Huamin Wang et al.
NATURE COMMUNICATIONS (2019)
METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway
Jian Wang et al.
FRONTIERS IN PHARMACOLOGY (2019)
YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
Yang Bai et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
Zi-Qi Zheng et al.
CANCER RESEARCH (2019)
Exosomes and their role in tumorigenesis and anticancer drug resistance
Neta Milman et al.
DRUG RESISTANCE UPDATES (2019)
Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
Edo Kon et al.
DRUG RESISTANCE UPDATES (2019)
Microenvironment plasticity confers cetuximab resistance
Peter Sidaway
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Integrins as biomechanical sensors of the microenvironment
Jenny Z. Kechagia et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The roles of DNA, RNA and histone methylation in ageing and cancer
Ewa M. Michalak et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
Seungwon Yang et al.
NATURE COMMUNICATIONS (2019)
Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer
Cheng Zhang et al.
CANCER MEDICINE (2019)
A Review in Research Progress Concerning m6A Methylation and Immunoregulation
Caiyan Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf et al.
DRUG RESISTANCE UPDATES (2019)
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
Alessandro Leonetti et al.
DRUG RESISTANCE UPDATES (2019)
Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
Wen Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion
Tianfang Xia et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
Katelyn Melgar et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
Yuanming Cheng et al.
CELL REPORTS (2019)
N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
Huan Jin et al.
EBIOMEDICINE (2019)
Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG
Katherine I. Zhou et al.
MOLECULAR CELL (2019)
RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway
Jiarong Cai et al.
ONCOTARGETS AND THERAPY (2019)
Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy
Yongjie Wang et al.
EPIGENOMICS (2019)
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi et al.
NATURE COMMUNICATIONS (2019)
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
Marco Tucci et al.
FRONTIERS IN ONCOLOGY (2019)
Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
M. Helena Vasconcelos et al.
DRUG RESISTANCE UPDATES (2019)
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
Luciana P. Rangel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage
Zhangjian Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Chromatin regulatory mechanisms and therapeutic opportunities in cancer
Alfredo M. Valencia et al.
NATURE CELL BIOLOGY (2019)
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies
Utthara Nayar et al.
NATURE GENETICS (2019)
m6A modification controls the innate immune response to infection by targeting type I interferons
Roni Winkler et al.
NATURE IMMUNOLOGY (2019)
Cancer immunoediting and resistance to T cell-based immunotherapy
Jake S. O'Donnell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Clinical epigenetics: seizing opportunities for translation
Maria Berdasco et al.
NATURE REVIEWS GENETICS (2019)
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Reading, writing and erasing mRNA methylation
Sara Zaccara et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
A. Visvanathan et al.
ONCOGENE (2018)
Restoration of conformation of mutant p53
J. A. Green et al.
ANNALS OF ONCOLOGY (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong et al.
CELL RESEARCH (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
Thorsten Stiewe et al.
DRUG RESISTANCE UPDATES (2018)
Redundant angiogenic signaling and tumor drug resistance
Rajesh N. Gacche et al.
DRUG RESISTANCE UPDATES (2018)
The complex relationship between TFEB transcription factor phosphorylation and subcellular localization
Rosa Puertollano et al.
EMBO JOURNAL (2018)
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC
Roberta Minari et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting -catenin through mRNA demethylation
Shun Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Jing Wen et al.
MOLECULAR CELL (2018)
Recognition of RNA N6- methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huilin Huang et al.
NATURE CELL BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage
Maria Castejon-Grinan et al.
ONCOGENE (2018)
The m(6)A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5 '-3 ' exoribonuclease XRN1
Jens Kretschmer et al.
RNA (2018)
Amazing Diversity in Biochemical Roles of Fe(II)/2-Oxoglutarate Oxygenases
Caitlyn Q. Herr et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
Qiang Zhang et al.
CELL DEATH & DISEASE (2018)
Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1
Baixing Wu et al.
NATURE COMMUNICATIONS (2018)
LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis
Ye Hong et al.
NATURE COMMUNICATIONS (2018)
N-6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
Yi Niu et al.
ACTA PHARMACEUTICA SINICA B (2018)
m6A RNA modification controls autophagy through upregulating ULK1 protein abundance
Shouheng Jin et al.
CELL RESEARCH (2018)
Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration
Hu Wang et al.
CELL RESEARCH (2018)
Identification of Natural Compound Radicicol as a Potent FTO Inhibitor
Ruiyong Wang et al.
MOLECULAR PHARMACEUTICS (2018)
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu et al.
NATURE CELL BIOLOGY (2018)
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T79OM-Positive Lung Cancer and Acquired Resistance to Osimertinib
Geoffrey R. Oxnard et al.
JAMA ONCOLOGY (2018)
A dynamic N-6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
Fei Yan et al.
CELL RESEARCH (2018)
MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
Alessandro Leonetti et al.
DRUG RESISTANCE UPDATES (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
Therapy resistance mediated by cancer stem cells
Teresa Bernadette Steinbichler et al.
SEMINARS IN CANCER BIOLOGY (2018)
Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
Benny Zhitomirsky et al.
CELL DEATH & DISEASE (2018)
ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
Hongbo Zhao et al.
FRONTIERS IN PHARMACOLOGY (2018)
Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074
Bernhard Englinger et al.
CELLS (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Endothelial-specific m6A modulates mouse hematopoietic stem and progenitor cell development via Notch signaling
Junhua Lv et al.
CELL RESEARCH (2018)
Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia
Sujan Piya et al.
AUTOPHAGY (2017)
Transporter effects on cell permeability in drug delivery
Abhirup Mandal et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
Marina Senek et al.
MOVEMENT DISORDERS (2017)
MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein
Zhe Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Drugging the Cancers Addicted to DNA Repair
Jac A. Nickoloff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
Pingting Zhou et al.
MOLECULAR CANCER (2017)
MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer
Shigeki Nanjo et al.
MOLECULAR CANCER THERAPEUTICS (2017)
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Hua-Bing Li et al.
NATURE (2017)
RNA m6A methylation regulates the ultraviolet-induced DNA damage response
Yang Xiang et al.
NATURE (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
R. R. Somasagara et al.
ONCOGENE (2017)
New strategies for targeting drug combinations to overcome mutation-driven drug resistance
Linyan Wang et al.
SEMINARS IN CANCER BIOLOGY (2017)
m6A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression
Jean-Yves Roignant et al.
TRENDS IN GENETICS (2017)
A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes
Qiuhong Li et al.
NATURE COMMUNICATIONS (2017)
Reduced m6A mRNA methylation is correlated with the progression of human cervical cancer
Xiuli Wang et al.
ONCOTARGET (2017)
The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma
Xiao Li et al.
ONCOTARGET (2017)
Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs
Chan Zhou et al.
CELL REPORTS (2017)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline
Alexis S. Bailey et al.
ELIFE (2017)
YTHDC1 mediates nuclear export of N6 - methyladenosine methylated mRNAs
Ian A. Roundtree et al.
ELIFE (2017)
Drugging the Cancers Addicted to DNA Repair
Jac A. Nickoloff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs
Ahmed S. Warda et al.
EMBO REPORTS (2017)
The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus
Qingliang Zheng et al.
NATURE IMMUNOLOGY (2017)
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
Deborah R. Caswell et al.
BMC MEDICINE (2017)
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
M. A. Qazi et al.
ANNALS OF ONCOLOGY (2017)
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges
Yael Diesendruck et al.
DRUG RESISTANCE UPDATES (2017)
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance
Maya Bar-Zeev et al.
DRUG RESISTANCE UPDATES (2017)
YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA
Hailing Shi et al.
CELL RESEARCH (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
HNRNPC as a candidate biomarker for chemoresistance in gastric cancer
Hao Huang et al.
TUMOR BIOLOGY (2016)
A Novel Inhibitor of the Obesity-Related Protein FTO
Yan Qiao et al.
BIOCHEMISTRY (2016)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
Sandra Ortiz-Cuaran et al.
CLINICAL CANCER RESEARCH (2016)
Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets
Giridhar Mudduluru et al.
DRUG RESISTANCE UPDATES (2016)
Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer
Shachar Raz et al.
DRUG RESISTANCE UPDATES (2016)
Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
Ruud H. Wijdeven et al.
DRUG RESISTANCE UPDATES (2016)
Lysosomes as mediators of drug resistance in cancer
Benny Zhitomirsky et al.
DRUG RESISTANCE UPDATES (2016)
Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
Wen Li et al.
DRUG RESISTANCE UPDATES (2016)
Cancer stem cells Role in tumor growth, recurrence, metastasis, and treatment resistance
Jenny C. Chang
MEDICINE (2016)
Nuclear m6A Reader YTHDC1 Regulates mRNA Splicing
Wen Xiao et al.
MOLECULAR CELL (2016)
The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
Shuibin Lin et al.
MOLECULAR CELL (2016)
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Elisa M. Noll et al.
NATURE MEDICINE (2016)
A framework for understanding and targeting residual disease in oncogene-driven solid cancers
Trever G. Bivona et al.
NATURE MEDICINE (2016)
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
Chuanzhao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation
Yunshu Wu et al.
STEM CELLS AND DEVELOPMENT (2016)
Histone Modifications and Cancer
James E. Audia et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
p53 in the DNA-Damage-Repair Process
Ashley B. Williams et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions
Janne T. Backman et al.
PHARMACOLOGICAL REVIEWS (2016)
DNA damage and the balance between survival and death in cancer biology
Wynand P. Roos et al.
NATURE REVIEWS CANCER (2016)
Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
J. E. Allen et al.
CANCER RESEARCH (2015)
N6-methyladenosine Modulates Messenger RNA Translation Efficiency
Xiao Wang et al.
CELL (2015)
m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
Tong Chen et al.
CELL STEM CELL (2015)
Coordination of m6A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming
Francesca Aguilo et al.
CELL STEM CELL (2015)
Molecular basis of resistance to proteasome inhibitors in hematological malignancies
Denise Niewerth et al.
DRUG RESISTANCE UPDATES (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
Raymond Pagliarini et al.
EMBO REPORTS (2015)
Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
Helena Joyce et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)
Wu He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression
Amy S. Y. Lee et al.
NATURE (2015)
N6-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions
Nian Liu et al.
NATURE (2015)
m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation
Shay Geula et al.
SCIENCE (2015)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N-6-methyladenosine demethylase FTO
Joel D. W. Toh et al.
CHEMICAL SCIENCE (2015)
Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid
Alejandro D. Soriano-Hernandez et al.
ONCOLOGY LETTERS (2015)
Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
Yue Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells
A. Dekanty et al.
ONCOGENE (2015)
Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
Benny Zhitomirsky et al.
ONCOTARGET (2015)
Emerging cytokine networks in colorectal cancer
Nathan R. West et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Synthesis of a FTO Inhibitor with Anticonvulsant Activity
Guanqun Zheng et al.
ACS CHEMICAL NEUROSCIENCE (2014)
m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells
Pedro J. Batista et al.
CELL STEM CELL (2014)
Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-stranded N6-Methyladenosine RNA Demethylation
Chao Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10-Mediated Paclitaxel Resistance: A Preclinical Study
Rishil J. Kathawala et al.
MOLECULAR CANCER THERAPEUTICS (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Hubing Shi et al.
CANCER DISCOVERY (2014)
Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
Rishil J. Kathawala et al.
CHINESE JOURNAL OF CANCER (2014)
Rationally designed nanovehicles to overcome cancer chemoresistance
Yoav D. Livney et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Guanqun Zheng et al.
MOLECULAR CELL (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Targeting the BRAF V600E Mutation in Multiple Myeloma
Mindaugas Andrulis et al.
CANCER DISCOVERY (2013)
From tumor prevention to therapy: Empowering p53 to fight back
Christian Frezza et al.
DRUG RESISTANCE UPDATES (2012)
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Nitzan Gonen et al.
DRUG RESISTANCE UPDATES (2012)
Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation
Alejandro D. Soriano-Hernandez et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
Baoen Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs-Dependent DNA Double-Strand Break Repair
Mahmoud Toulany et al.
MOLECULAR CANCER RESEARCH (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics
Vicky Goler-Baron et al.
PLOS ONE (2012)
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
Y. Adar et al.
CELL DEATH & DISEASE (2012)
Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Kristy J. Gotink et al.
CLINICAL CANCER RESEARCH (2011)
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Alina Shapira et al.
DRUG RESISTANCE UPDATES (2011)
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress
S. A. Kamranvar et al.
LEUKEMIA (2011)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
DNA double-strand break - induced pro-survival signaling
Amy J. Hawkins et al.
RADIOTHERAPY AND ONCOLOGY (2011)
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Yehuda G. Assaraf
DRUG RESISTANCE UPDATES (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
